Dublin

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Multiple sclerosis2 trials
• Chronic myeloid leukaemia1 trial

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Completed4 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals5 trials

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

  NCT07225504· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple sclerosis1 recruiting

Closed trials

• Completed

  LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung Cancer

  NCT01828099· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib

  NCT01828112· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

  NCT01784068· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  The Gilenya Pregnancy Registry

  NCT01285479· Novartis Pharmaceuticals· Source